We purchased 500 shares of Affirm in our high growth portfolio near its opening price. That increased the size of our holding of Affirm to 800 shares at an average acquisition cost of $41 Our position is now a 3.9% holding. This will be reflected in the charts we send next week. We had spoken…
We made 2 changes in our model portfolios. As we have indicated in previous weekly commentaries, we sold our FIS position. We sold it at the opening this morning, 1/26 and we received $110.55. The proceeds of the sale netted $13,925. We originally bought the shares more than 4 years ago for $91.59. Obviously that…
We finally pulled the trigger on a portfolio rebalance, eliminating our position in the shares of Veeva, and adding to our holding of Upstart. Overall, the transaction reduced our margin balance by a minimal level of just over $600. Our margin balance is as high as I find comfortable given the vicissitudes that market has…
Additional Portfolio changes: Sale of 185 Asana (ASAN) and purchase of 395 shares of GLBE We have made another portfolio transaction today, reducing our holding of Asana by 185 shares and adding 380 shares of Global-E. The portfolio now holds 400 shares of Asana, and 670 shares of Global=E. These changes, and the other changes…
The charts and the comparative commentary will return shortly. Sorry for the interruption, but we want to provide subscribers with a better experience and we need to re-do the format of the charts and automate their preparation so they are more legible and are less likely to have calculational errors. Last week started with what…
As suggested in previous posts, we have taken advantage of Doximity’s recent share price compression to add to our position. The shares were weak this morning, August 30, 2021 and so we doubled the size of our position by buying 225 additional shares at a price of $77.99/share. The purchase cost $!7,230. As indicated in…
As we had previously discussed we have finally eliminated the position in CTXS shares that we had held at Friday’s closing price of $103.22. While I do not feel that the Citrix dividend is at risk, the company’s transitions have apparently been mis-managed and have led to multiple guide-downs. I think it is better to…
As mentioned in past portfolio commentaries, our holding in PTC was simply too small in terms of our portfolio management methodology. While we felt that the reaction of PTC to its most recent earnings release and guidance left the shares at a bargain valuation with an EV/S of just 8.7X, we wanted to eliminate an…
As many subscribers are aware, Medallia announced today that it was being bought by P/E firm, Thoma Brava at a $34 price per share. We were quite disappointed by that price -indeed the EV/S valuation implicit in that transaction is less than 8X, which is quite a bargain in our mind. Qualtrics, Medallia’s principal competitor,…
We made a small change in the High Growth portfolio this morning. We chose to sell about 40% of our PTC holding at a small profit, and to buy a small position in Shift4 with the proceeds of that sale. We simply didn’t wish to increase our margin position. Currently our margin position is about…